Specifically, when the expression of dimeric PKM2 is preferred, it can regulate aerobic glycolysis through metabolic reprogramming of cancer cell metabolic pathways, leading to increased macromolecular biosynthesis in cancer cells and accelerated cancer cell growth. Here, PKM is linked to cancer.